logo
Fortis Mohali introduces dTMS therapy, offering new hope to patients battling depression, OCD, PTSD

Fortis Mohali introduces dTMS therapy, offering new hope to patients battling depression, OCD, PTSD

Indian Express17-07-2025
In a breakthrough for advanced mental health care in the Tricity region, Fortis Hospital Mohali has introduced deep transcranial magnetic stimulation (dTMS), a non-invasive FDA-approved brain stimulation therapy providing new hope to patients who have not responded to traditional medication or psychotherapy.
The therapy has already been used to treat 15 patients with obsessive compulsive disorder (OCD). The dTMS was introduced so that it can penetrate deeper and stimulate areas of the brain that repetitive transcranial magnetic stimulation (rTMS) cannot reach, making it a more effective option for certain treatment-resistant conditions.
Dr Hardeep Singh, additional director, psychiatry, Fortis Hospital, Mohali, highlighted successful clinical outcomes post using dTMS.
A 40-year-old woman who had been living under the relentless grip of severe OCD for nearly 16 years, consumed by overwhelming fears of contamination, she spent hours each day performing exhausting cleaning rituals, leaving her physically drained and virtually confined to her home. Despite seeking help from several leading medical centres over the years, her symptoms persisted at an extreme level, severely impacting her quality of life. She was kept on dTMS to target deeper brain regions involved in OCD.
'Within just six weeks of dTMS treatment, her condition improved dramatically. Her Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) score, a standard measure of OCD severity, dropped significantly from 32, indicating extreme symptoms, to 13, reflecting only mild OCD. She has been able to regain control over her life, dramatically reducing her compulsions and reclaiming her independence. The therapy is revolutionising the way we treat depression and other neuropsychiatric disorders. It's a precise and safe therapy that provides long-term relief without the side effects of traditional medications,' Singh explained.
The dTMS works by delivering targeted magnetic pulses to stimulate specific regions of the brain implicated in various mental health and neurological conditions. It has shown remarkable efficacy in treating OCD, PTSD, anxiety, chronic pain, migraines, and nicotine addiction. Researchers are also exploring its potential benefits in managing Parkinson's disease, Tourette's syndrome and autism. Patients typically undergo 20-30 outpatient sessions over 4 to 6 weeks. The treatment is completely non-invasive and does not require anesthesia, and patients remain awake and communicative throughout the session.
Dr Nishit Sawal, Senior Consultant, Neurology, said, 'dTMS is also helpful for treating post-stroke patients for aphasia and post-stroke rehabilitation. Aphasia is a language disorder that affects a person's ability to communicate. It can impact speaking, understanding, reading and writing. Aphasia is usually caused by damage to language-related areas of the brain, often due to stroke or head injury.'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

AAP officials review progress of anti drug campaign in Ludhiana ahead of chief minister meeting
AAP officials review progress of anti drug campaign in Ludhiana ahead of chief minister meeting

Time of India

time5 hours ago

  • Time of India

AAP officials review progress of anti drug campaign in Ludhiana ahead of chief minister meeting

1 2 3 Ludhiana: Senior Aam Aadmi Party (AAP) leaders spearheading Punjab's anti-drug drive held strategy talks with police and district officials on Saturday, ahead of a key meeting with Chief Minister Bhagwant Mann scheduled for Monday. The session, held at a resort on Ferozepur Road, saw AAP Ludhiana incharge Balbir Chaudhary and 'Nasha Mukti Morcha' zone incharge Sukhjit Singh review local progress under the 'Yudh Nashe Virudh' (War Against Drugs) campaign. Officials said the meeting was aimed at preparing a report for the CM on Ludhiana's enforcement and rehabilitation efforts. Chaudhary briefed attendees on local de-addiction and awareness initiatives, stressing continuous outreach to Punjab's youth. Singh claimed growing public engagement with the anti-drug movement, but urged stronger collaboration between civil society and law enforcement to deepen impact. "Coordination across the administration, police, and grassroots activists is key," Singh said, noting that Monday's meeting with Mann will evaluate government scheme effectiveness, propose de-addiction centre expansions, and discuss bolstering local policing capabilities. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Gentle Japanese hair growth method for men and women's scalp Hair's Rich Learn More Undo The 'Yudh Nashe Virudh' campaign, launched by the Mann government shortly after AAP's 2022 electoral victory in Punjab, aims to tackle the state's long-standing drug problem through a mix of law enforcement, rehabilitation, and awareness. The 'Nasha Mukti Morcha' (Drug-Free Front), AAP's volunteer wing in the campaign, has been organising rallies, community outreach events, and facilitating rehab referrals across districts. Punjab has struggled with drug abuse for more than a decade, particularly in border areas where narcotics smuggling from across the Pakistan border remains a major challenge. In recent years, synthetic drugs and injectable opioids have worsened the crisis, prompting calls for a multi-pronged response. The AAP government has vowed to make anti-drug action a top priority. Its critics, however, argue that while raids and arrests have increased, structural issues such as underfunded rehab centres and weak inter-agency coordination persist. Monday's CM-level review is expected to address many of these concerns and plot the next stage of the campaign. MSID:: 123077794 413 | Get the latest lifestyle updates on Times of India, along with Friendship Day wishes , messages and quotes !

Over 29,000 Kg Of Butter Recalled In US For This Serious Reason
Over 29,000 Kg Of Butter Recalled In US For This Serious Reason

NDTV

time7 hours ago

  • NDTV

Over 29,000 Kg Of Butter Recalled In US For This Serious Reason

More than 29,000 kilos (64,800 pounds) of butter have been voluntarily recalled after it was discovered the packaging forgot to mention a crucial detail - it contains milk. Milk in butter might sound obvious, right? But when it is not listed on the label and someone with a milk allergy unknowingly consumes it, things can get serious real quick. On July 30, the US Food and Drug Administration (FDA) classified the recall as a 'Class II' level. That is one notch below the most urgent level. According to the FDA website, a Class II recall refers to "a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote." Here, a 'recall' is a safety step to remove or correct a product that is not meeting regulatory standards or could harm consumers. The butter being recalled is from Bunge North America Inc., a food company based in Missouri. On July 14, they voluntarily recalled 1,800 cases of their NH European Style Butter Blend (500 gm packs). Each case had 36 blocks of butter, packed in white paperboard boxes. The problem? Milk, a major food allergen, wasn't mentioned anywhere on the product label. The company said the recalled butter was sent to 12 distribution centres across the US and one in the Dominican Republic. So far, there is no official word from the FDA on whether anyone has fallen ill from eating the product. Allergen labelling rules are in place for a reason. As the FDA explains, food-related allergic reactions can range from mild (like hives, vomiting, diarrhoea or lip swelling) to severe, life-threatening ones like anaphylaxis. That is when the immune system goes into overdrive and releases a flood of chemicals, sending the body into shock. This is potentially fatal if not treated quickly. Because of such risks, the FDA enforces strict regulations to make sure allergens are clearly declared on packaging. The FDA advises that if someone with a milk allergy has already eaten the butter and is experiencing symptoms, "stop eating the food immediately, evaluate the need to use emergency medication (such as epinephrine) and seek medical attention." Butter is made from cream, not straight from plain milk. The cream is separated, pasteurised, then churned until fat separates and forms butter. That clumpy fat is processed, washed, worked, sometimes salted, and packaged into the block you buy. Earlier this week, High Noon Hard Seltzers were recalled after a labelling mix-up led to some vodka-filled cans being mistakenly packaged as non-alcoholic Celsius Astro Vibe Energy Drink. Read all about it here.

Study alleging widespread antibiotic contamination in Indian rivers based on assumptions: Govt
Study alleging widespread antibiotic contamination in Indian rivers based on assumptions: Govt

The Hindu

time14 hours ago

  • The Hindu

Study alleging widespread antibiotic contamination in Indian rivers based on assumptions: Govt

A recent study alleging widespread antibiotic contamination in Indian rivers is based on "simulations and assumptions" and therefore, no conclusion on the issue can be drawn from it, the government has said. Replying to a question by Congress MP Pramod Tiwari in the Rajya Sabha on Friday, Union Minister of State for Environment Kirti Vardhan Singh said the study has cited its "own limitations of data availability". Study findings The study, conducted by researchers from McGill University, alleged that 80 per cent of the total length of rivers in India could be posing environmental and health risks due to antibiotic pollution. The media report, published on April 24, 2025, is based on a study titled 'Antibiotics in the global river system arising from human consumption' conducted by researchers from McGill University, Canada, and its "findings are based on simulations and assumptions", the minister said in a written reply. Furthermore, the minister informed that the government has not conducted any study on antibiotic contamination of rivers. Regarding the steps taken to regulate pharmaceutical waste and strengthen pollution control, Singh informed that the government launched the National Action Plan on Antimicrobial Resistance (NAP-AMR) in April 2017 to develop and implement strategic interventions to reduce the environmental impact of antimicrobial resistance through effective waste management and safe disposal of expired antimicrobials. He mentioned that the environment ministry issued a notification for the bulk drug and pharmaceutical industry in August 2021, classifying chemical and biological sludge or any residue generated from wastewater treatment as hazardous waste. These shall be managed in an environmentally sound manner in accordance with the Hazardous Waste and Other Wastes (Management and Transboundary Movement) Rules, 2016, Singh added. He highlighted that state pollution control boards have been empowered to prescribe additional relevant parameters and monitoring frequencies based on local conditions. The expired antimicrobials are disposed of by manufacturers or suppliers through incineration as per the Bio-medical Waste Management Rules, 2016, while sludge from effluent treatment plants is sent to common biomedical or hazardous waste treatment facilities for incineration or safe disposal. "To reduce antibiotic residue from effluent sources, industries are adopting reduce, recycle and reuse of treated effluent to maximise the extent of Zero Liquid Discharge to minimise the risk of pharmaceutical compound residues," the minister said.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store